Silvant Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $438K | Hold |
1,245
| – | – | 0.02% | 174 |
|
|
2025
Q4 | $408K | Hold |
1,245
| – | – | 0.01% | 169 |
|
|
2025
Q3 | $351K | Hold |
1,245
| – | – | 0.01% | 173 |
|
|
2025
Q2 | $348K | Hold |
1,245
| – | – | 0.01% | 170 |
|
|
2025
Q1 | $388K | Hold |
1,245
| – | – | 0.02% | 164 |
|
|
2024
Q4 | $324K | Hold |
1,245
| – | – | 0.01% | 168 |
|
|
2024
Q3 | $401K | Hold |
1,245
| – | – | 0.02% | 160 |
|
|
2024
Q2 | $389K | Hold |
1,245
| – | – | 0.02% | 160 |
|
|
2024
Q1 | $354K | Hold |
1,245
| – | – | 0.02% | 166 |
|
|
2023
Q4 | $359K | Hold |
1,245
| – | – | 0.02% | 159 |
|
|
2023
Q3 | $335K | Hold |
1,245
| – | – | 0.02% | 162 |
|
|
2023
Q2 | $276K | Hold |
1,245
| – | – | 0.02% | 164 |
|
|
2023
Q1 | $301K | Hold |
1,245
| – | – | 0.02% | 158 |
|
|
2022
Q4 | $327K | Hold |
1,245
| – | – | 0.02% | 154 |
|
|
2022
Q3 | $281K | Hold |
1,245
| – | – | 0.02% | 174 |
|
|
2022
Q2 | $303K | Hold |
1,245
| – | – | 0.07% | 124 |
|
|
2022
Q1 | $301K | Hold |
1,245
| – | – | 0.06% | 143 |
|
|
2021
Q4 | $280K | Hold |
1,245
| – | – | 0.05% | 157 |
|
|
2021
Q3 | $265K | Hold |
1,245
| – | – | 0.05% | 163 |
|
|
2021
Q2 | $303K | Hold |
1,245
| – | – | 0.05% | 156 |
|
|
2021
Q1 | $310K | Hold |
1,245
| – | – | 0.05% | 155 |
|
|
2020
Q4 | $286K | Hold |
1,245
| – | – | 0.05% | 162 |
|
|
2020
Q3 | $316K | Hold |
1,245
| – | – | 0.06% | 144 |
|
|
2020
Q2 | $294K | Hold |
1,245
| – | – | 0.05% | 141 |
|
|
2020
Q1 | $252K | Hold |
1,245
| – | – | 0.05% | 134 |
|
|
2019
Q4 | $300K | Hold |
1,245
| – | – | 0.05% | 148 |
|
|
2019
Q3 | $241K | Sell |
1,245
-274
| -18% | -$52.6K | 0.05% | 165 |
|
|
2019
Q2 | $280K | Hold |
1,519
| – | – | 0.05% | 163 |
|
|
2019
Q1 | $289K | Hold |
1,519
| – | – | 0.05% | 158 |
|
|
2018
Q4 | $296K | Hold |
1,519
| – | – | 0.06% | 147 |
|
|
2018
Q3 | $315K | Hold |
1,519
| – | – | 0.04% | 157 |
|
|
2018
Q2 | $280K | Hold |
1,519
| – | – | 0.03% | 171 |
|
|
2018
Q1 | $259K | Buy |
+1,519
| New | +$279K | 0.03% | 181 |
|
Other funds holding AMGN
VCM
VPM
Silvant Capital Management's AMGN Position: Q1 2026 in Review
Silvant Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 1,245 shares worth $438K. The position accounts for 0.02% of the portfolio, ranked #174.
Silvant Capital Management first reported a position in AMGN in Q1 2018 and has held it in 33 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Silvant Capital Management held 1,245 shares of Amgen worth $438K as of Q1 2026.
- Silvant Capital Management left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.02% of Silvant Capital Management's portfolio in Q1 2026, its #174 holding.
- Silvant Capital Management first reported a position in Amgen in Q1 2018 and has held it in 33 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.